Oncology Institute (TOI) Short Interest Ratio & Short Volume $0.89 0.00 (-0.45%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$0.88 -0.01 (-1.67%) As of 02/21/2025 06:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Oncology Institute Short Interest DataOncology Institute (TOI) has a short interest of 324,300 shares, representing 0.88% of the float (the number of shares available for trading by the public). This marks a -7.63% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 708,592 shares to cover all short positions.Current Short Interest324,300 sharesPrevious Short Interest351,100 sharesChange Vs. Previous Month-7.63%Dollar Volume Sold Short$324,300.00Short Interest Ratio0.2 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares75,560,000 sharesFloat Size36,800,000 sharesShort Percent of Float0.88%Today's Trading Volume252,993 sharesAverage Trading Volume708,592 sharesToday's Volume Vs. Average36% Short Selling Oncology Institute? Sign up to receive the latest short interest report for Oncology Institute and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTOI Short Interest Over TimeTOI Days to Cover Over TimeTOI Percentage of Float Shorted Over Time Oncology Institute Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/2025324,300 shares $324,300.00 -7.6%0.9%0.2 $1.00 1/15/2025351,100 shares $140,440.00 +8.3%1.0%0.2 $0.40 12/31/2024324,100 shares $100,146.90 +86.8%0.9%0.2 $0.31 12/15/2024173,500 shares $38,673.15 -86.0%0.5%0.1 $0.22 11/30/20241,240,000 shares $200,880.00 +193.9%3.4%0.8 $0.16 11/15/2024421,900 shares $75,942.00 +70.1%1.1%0.4 $0.18 10/31/2024248,000 shares $76,880.00 -1.5%0.7%1.7 $0.31 10/15/2024251,800 shares $80,802.62 -0.3%0.8%2 $0.32 9/30/2024252,500 shares $82,542.25 +8.4%0.8%2 $0.33 9/15/2024233,000 shares $76,703.60 -22.8%0.7%1.8 $0.33 Get the Latest News and Ratings for TOI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024301,700 shares $108,853.36 +25.2%0.9%2.1 $0.36 8/15/2024240,900 shares $86,242.20 +9.6%0.7%1.4 $0.36 7/31/2024219,900 shares $120,065.40 -15.8%0.7%1.3 $0.55 7/15/2024261,000 shares $130,500.00 -13.5%0.8%1.5 $0.50 6/30/2024301,800 shares $138,828.00 +29.8%1.0%1.8 $0.46 6/15/2024232,600 shares $104,670.00 +13.2%0.7%1.3 $0.45 5/31/2024205,500 shares $101,558.10 -5.6%0.7%1.1 $0.49 5/15/2024217,600 shares $148,838.40 -18.9%0.7%1.3 $0.68 4/30/2024268,400 shares $284,504.00 +6.5%0.9%2.2 $1.06 4/15/2024252,000 shares $299,880.00 -4.1%0.8%2.2 $1.19 3/31/2024262,700 shares $415,066.00 +12.1%0.8%2.1 $1.58 3/15/2024234,300 shares $393,624.00 +3.8%0.8%1.7 $1.68 2/29/2024225,700 shares $424,316.00 -7.0%0.7%1.2 $1.88 2/15/2024242,600 shares $434,254.00 -20.8%0.8%1.1 $1.79 1/31/2024306,200 shares $627,710.00 -7.5%1.0%1.1 $2.05 1/15/2024330,900 shares $684,963.00 +20.3%0.8%1.1 $2.07 12/31/2023275,000 shares $561,000.00 +51.3%0.7%0.9 $2.04 12/15/2023181,800 shares $245,430.00 -35.0%0.7%0.6 $1.35 11/30/2023279,800 shares $478,458.00 -37.4%1.1%1 $1.71 11/15/2023447,000 shares $992,340.00 +91.3%1.7%1.8 $2.22 10/31/2023233,700 shares $446,367.00 -4.6%0.9%1 $1.91 10/15/2023245,000 shares $379,750.00 -8.8%0.9%1.2 $1.55 9/30/2023268,500 shares $375,900.00 +6.2%1.0%1 $1.40 9/15/2023252,900 shares $417,285.00 -11.9%1.0%0.9 $1.65 8/31/2023286,900 shares $332,804.00 -17.9%0.9%0.4 $1.16 8/15/2023349,300 shares $299,629.54 +42.0%1.1%0.4 $0.86 7/31/2023246,000 shares $240,440.40 -45.3%0.8%0.3 $0.98 7/15/2023450,000 shares $319,635.00 -7.3%1.4%0.5 $0.71 6/30/2023485,400 shares $267,067.08 -74.3%1.5%0.6 $0.55 6/15/20231,890,000 shares $1.14 million +39.0%6.0%2.4 $0.61Why Buffett and 100 members of Congress are Piling into this One Investment (Ad)This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> 5/31/20231,360,000 shares $581,400.00 +5.4%4.4%2.1 $0.43 5/15/20231,290,000 shares $580,500.00 +1.6%4.1%6.6 $0.45 4/30/20231,270,000 shares $647,700.00 +5.8%4.1%7.4 $0.51 4/15/20231,200,000 shares $716,760.00 +2.6%3.9%6.9 $0.60 3/31/20231,170,000 shares $793,143.00 +13.6%3.8%7.2 $0.68 3/15/20231,030,000 shares $682,066.00 +12.0%3.5%5.7 $0.66 2/28/2023919,300 shares $1.30 million -21.4%3.2%6.7 $1.41 2/15/20231,170,000 shares $1.83 million -14.6%4.0%6.9 $1.56 1/31/20231,370,000 shares $2.03 million +31.7%4.7%7.1 $1.48 1/15/20231,040,000 shares $1.77 million +4.0%3.6%5.2 $1.70 12/30/20221,000,000 shares $1.65 million -8.3%3.8%5.1 $1.65 12/15/20221,090,000 shares $1.00 million +39.6%4.2%5.6 $0.92 11/30/2022780,600 shares $1.10 million -17.0%3.0%3.9 $1.41 11/15/2022940,500 shares $1.92 million -3.4%3.6%5.6 $2.04 10/31/2022973,100 shares $4.42 million -8.2%3.7%7 $4.54 10/15/20221,060,000 shares $4.71 million -18.5%4.1%8.4 $4.44 9/30/20221,300,000 shares $6.02 million +46.7%5.1%10.8 $4.63 9/15/2022886,100 shares $4.08 million -6.6%3.5%6 $4.61 8/31/2022948,900 shares $6.03 million +0.0%3.7%7.8 $6.35 8/15/2022948,700 shares $5.87 million +8.1%3.8%7.5 $6.19 7/31/2022878,000 shares $5.67 million -4.3%3.5%6.8 $6.46 7/15/2022917,000 shares $5.36 million +15.0%3.6%6.7 $5.84 6/30/2022797,600 shares $4.04 million +83.2%3.1%5.7 $5.06 6/15/2022435,400 shares $2.79 million -24.7%1.7%3.1 $6.40 5/31/2022578,100 shares $5.21 million +5.2%2.3%5.6 $9.01 5/15/2022549,300 shares $3.36 million -8.6%2.2%4.7 $6.12 4/30/2022600,800 shares $4.72 million +5.0%2.5%5.8 $7.86 4/15/2022572,000 shares $3.95 million +3.2%2.4%6.1 $6.90 3/31/2022554,100 shares $3.95 million +9.0%2.2%5.8 $7.13 3/15/2022508,500 shares $3.48 million -21.6%2.0%4.3 $6.84 2/28/2022648,800 shares $3.48 million +4.9%2.5%5.2 $5.37 2/15/2022618,500 shares $3.90 million 0.0%2.4%4.8 $6.31 1/31/2022618,700 shares $4.00 million +2.3%2.4%4.5 $6.46 1/15/2022605,100 shares $4.74 million +8.7%2.3%3.8 $7.83 12/31/2021556,500 shares $5.43 million No Change2.2%3.6 $9.75 TOI Short Interest - Frequently Asked Questions What is Oncology Institute's current short interest? Short interest is the volume of Oncology Institute shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 324,300 shares of TOI short. 0.88% of Oncology Institute's shares are currently sold short. Learn More on Oncology Institute's current short interest. What is a good short interest percentage for Oncology Institute? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.88% of Oncology Institute's floating shares are currently sold short. Is Oncology Institute's short interest increasing or decreasing? Oncology Institute saw a decline in short interest during the month of January. As of January 31st, there was short interest totaling 324,300 shares, a decline of 7.6% from the previous total of 351,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Oncology Institute's float size? Oncology Institute currently has issued a total of 75,560,000 shares. Some of Oncology Institute's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Oncology Institute currently has a public float of 36,800,000 shares. How does Oncology Institute's short interest compare to its competitors? 0.88% of Oncology Institute's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Oncology Institute: Biodesix, Inc. (0.51%), Sera Prognostics, Inc. (3.93%), Quipt Home Medical Corp. (3.89%), EUDA Health Holdings Limited (0.05%), P3 Health Partners Inc. (2.44%), Exagen Inc. (0.30%), Burning Rock Biotech Limited (0.68%), Enzo Biochem, Inc. (0.79%), Concord Medical Services Holdings Limited (0.19%), NewGenIvf Group Limited (3.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Oncology Institute stock? Short selling TOI is an investing strategy that aims to generate trading profit from Oncology Institute as its price is falling. TOI shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Oncology Institute? A short squeeze for Oncology Institute occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TOI, which in turn drives the price of the stock up even further. How often is Oncology Institute's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TOI, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies Biodesix Short Interest Sera Prognostics Short Interest Quipt Home Medical Short Interest EUDA Health Short Interest P3 Health Partners Short Interest Exagen Short Interest Burning Rock Biotech Short Interest Enzo Biochem Short Interest Concord Medical Services Short Interest NewGenIvf Group Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TOI) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
